The putative role of RNASET2 in human ovarian cancer suppression was later supported by a report showing a marked downregulation of RNASET2 expression in both carboplatin- and cisplatin-resistant A2780 ovarian cancer cell lines compared to their parental counterparts (Figure 1E) [97]. This evidence concerns the gene RNASET2 and ovarian cancer.